COVID-19-Induced Guillain-Barré Syndrome

This case report involves a 47-year-old male who presented to the emergency department (ED) with a positive coronavirus disease 2019 (COVID-19) test and symptoms of Guillain-Barré syndrome (GBS). Electrodiagnostic (EDX) studies reported an acute inflammatory demyelinating polyradiculoneuropathy (AID...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Joseph E, Mix, Felicia M, Buck, Justin C, Walters, Reid A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Physical Medicine & Rehabilitation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693695/
https://www.ncbi.nlm.nih.gov/pubmed/34956793
http://dx.doi.org/10.7759/cureus.19809
_version_ 1784619196253995008
author Brooks, Joseph E
Mix, Felicia M
Buck, Justin C
Walters, Reid A
author_facet Brooks, Joseph E
Mix, Felicia M
Buck, Justin C
Walters, Reid A
author_sort Brooks, Joseph E
collection PubMed
description This case report involves a 47-year-old male who presented to the emergency department (ED) with a positive coronavirus disease 2019 (COVID-19) test and symptoms of Guillain-Barré syndrome (GBS). Electrodiagnostic (EDX) studies reported an acute inflammatory demyelinating polyradiculoneuropathy (AIDP). The patient underwent intravenous immune globulin (IVIG) treatment and four weeks of acute inpatient rehabilitation with some functional improvement but remained unable to ambulate independently at discharge.
format Online
Article
Text
id pubmed-8693695
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86936952021-12-23 COVID-19-Induced Guillain-Barré Syndrome Brooks, Joseph E Mix, Felicia M Buck, Justin C Walters, Reid A Cureus Physical Medicine & Rehabilitation This case report involves a 47-year-old male who presented to the emergency department (ED) with a positive coronavirus disease 2019 (COVID-19) test and symptoms of Guillain-Barré syndrome (GBS). Electrodiagnostic (EDX) studies reported an acute inflammatory demyelinating polyradiculoneuropathy (AIDP). The patient underwent intravenous immune globulin (IVIG) treatment and four weeks of acute inpatient rehabilitation with some functional improvement but remained unable to ambulate independently at discharge. Cureus 2021-11-22 /pmc/articles/PMC8693695/ /pubmed/34956793 http://dx.doi.org/10.7759/cureus.19809 Text en Copyright © 2021, Brooks et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Physical Medicine & Rehabilitation
Brooks, Joseph E
Mix, Felicia M
Buck, Justin C
Walters, Reid A
COVID-19-Induced Guillain-Barré Syndrome
title COVID-19-Induced Guillain-Barré Syndrome
title_full COVID-19-Induced Guillain-Barré Syndrome
title_fullStr COVID-19-Induced Guillain-Barré Syndrome
title_full_unstemmed COVID-19-Induced Guillain-Barré Syndrome
title_short COVID-19-Induced Guillain-Barré Syndrome
title_sort covid-19-induced guillain-barré syndrome
topic Physical Medicine & Rehabilitation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693695/
https://www.ncbi.nlm.nih.gov/pubmed/34956793
http://dx.doi.org/10.7759/cureus.19809
work_keys_str_mv AT brooksjosephe covid19inducedguillainbarresyndrome
AT mixfeliciam covid19inducedguillainbarresyndrome
AT buckjustinc covid19inducedguillainbarresyndrome
AT waltersreida covid19inducedguillainbarresyndrome

Ejemplares similares